Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
ļ»æ

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > MedTech Malta 2024 this November! šŸš€
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Post by jopatcloon Sep 13, 2024 6:50am
103 Views
Post# 36221762

MedTech Malta 2024 this November! šŸš€

MedTech Malta 2024 this November! šŸš€
Voir Angio Consult GmbH
Angio Consult GmbH a republi ceci
 
Exciting News!

I am thrilled to announce that I will be speaking at MedTech Malta 2024 this November!

I will be talking about the latest trends and innovations in medical technology, guiding you along the way of medical devices from concept to care.

Don't miss the chance to learn from leading experts and network with professionals from around the world. We hope to see you there!

Contact our team for a €150 discount code for Premium or Platinum tickets!

MedTechMalta AngioConsult InnovationInHealthcare MedicalTechnology Networking FutureOfHealthcare MedTech World Malta Enterprise VisitMalta Incentives & Meetings Malta Digital Innovation Authority
 
 
 
 

 

 
Ajouter un commentaire…
 
Interesting 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities